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Recently, in Polish Pneumology and Allergo­
logy an interesting paper from India presenting 15 
cases of pigeon fancier’s lung was published [1]. 
Patients with suspected bird fancier’s lung require 
comprehensive evaluation, hence the paper gives 
rise to the following remarks.
Clinical symptoms
Extrinsic allergic alveolitis (EAA) is not 
a uniform disease entity, but rather a complex 
dynamic clinical syndrome that varies in its 
initial presentation and clinical course [2]. Fink 
et al. have described EAA as occurring in acute, 
subacute and chronic forms [3]. The authors do 
not however specify how many of the patients 
presented with the acute, subacute or chronic 
course of the disease. An alternative classification 
system that emphasises the dynamic nature of 
the disease with acute progressive, acute inter­
mittent non­progressive and recurrent non­acute 
disease has been proposed [4]. However, the 
authors did not identify the course of disease in 
their patients. The study noted that in all of the 
patients crackles were audible upon respiration. 
Was there no wheezing heard in the patient with 
airway obstruction?
Characteristics of the exposure to bird spe­
cific antigens, such as time or duration are not 
well documented in the study. For the majority 
of patients with pigeon breeder’s lung in Poland 
contact with birds is a hobby and after diagnosis 
of disease avoidance of the causative antigen 
is usually easily achievable. It is more difficult 
however for patients with farmer’s  lung, since 
farmers work in harmful conditions because this 
work is the source of their livelihood [5]. It was 
not clearly stated but it would be beneficial to 
know; how many patients completely restricted 
contact with the causative antigen? It is not clear 
what treatment was administrated following dia­
gnosis of EAA in this group of 15 patients. Were 
there patients in this group treated with cortico­
steroids? It is important to know if patients with 
clinical symptoms and functional or radiological 
abnormalities were exposed to antigens.
Pulmonary function tests
Functional evaluation is an important part of 
the article, hence the title of the presented paper 
could be: Bird fancier’s lung — clinical, radiolog­
ical and functional presentation of 15 cases. It is 
difficult to accept the presentation and interpreta­
tion of pulmonary function tests in this study. The 
authors diagnosed restriction in 80% of patients 
on the basis of spirometry. It is not possible to 
diagnose this pattern of ventilatory disturbances 
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using spirometry alone, because although it can 
measure VC, it cannot measure TLC. A decrease 
in VC does not prove a restrictive pulmonary de­
fect. It may be suggestive of lung restriction when 
FEV1/VC is normal or increased [6]. A restrictive 
ventilatory defect is characterised by a reduction 
in TLC below the 5th percentile of the predicted 
value, and a normal FEV1/VC [6]. In the quoted 
by authors study of Morell et al. [7] restrictive 
defects were confirmed by body plethysmography.
Evaluation of spirometric severity of airways 
limitation using FEV1 in the group of patients with 
restrictive ventilator defect is very disputable. 
FEV1 is a recognized criterion of obstructive se­
verity with decrease in FEV1/VC below the limit. 
It would be more logical to use the old classifi­
cation of restriction severity which, according 
to ATS, is based on a decrease in (F)VC with 
normal FEV1/VC (mild­lower limit of the norm 
to 70%, moderate — 60−69%, severe­moderate 
— 50−59%, severe — 34−49%, very severe < 
34%) or even better based on TLC (mild­lower 
limit of the norm — 70%, moderate — 60−69%, 
severe less than 60%) [8]. It would have been 
better to limit the presentation of spirometric 
data to information on how many patients had 
a decrease in VC and a mean value with stan­
dard deviation. Plethysmography is helpful for 
evaluation of RV. Air trapping, which is typical 
for obstructive lung diseases, was observed in 
33% of patients in HRCT. It would be interesting 
to know the values of airway resistance and RV/
TLC. The authors dedicated too little space to the 
evaluation of oxygen diffusion. In Table 2, only 
1 patient was marked with an isolated decrease 
in DLco, although 13 patients had a moderate 
decrease in diffusion capacity [1]. The accurate 
elaboration of DLco was more important than 
presentation of FEV1 with details. Evaluation of 
respiratory sufficiency in these patients would 
have been very helpful. Arterial hypoxemia is 
a minor diagnostics criterion of EAA [9]. The 
authors indicated in Table 2 that a desaturation 
in the 6­min. walk test was observed in 73% of 
patients [1]. However, the values of SaO2 at rest 
and after effort were not shown in the paper. The 
value of PaO2 is also important in the early phase 
of diagnostics because it is one of the minor cri­
teria in the diagnosis of EAA [9].
Radiological image
The authors did not define what radiological 
abnormalities on the conventional chest X­ray 
were observed. Although HRCT is better for 
precise localisation, nature and assessment of 
the spread of pulmonary changes, conventional 
chest X­ray permits detection of patients with in­
terstitial lung diseases. It would be interesting to 
know how many patients had radiological chan­
ges in their chest X­ray, as well as the localisation 
and nature of the abnormalities. In two of the 
described cases mediastinal lymphadenopathy 
was observed. How big were these nodules? This 
is not a typical radiological finding for patients 
with EAA. In the big groups of patients with EAA 
shown in the paper in Table 3 lymphadenopathy 
was not demonstrated. It could be inferred that 
this lymphadenopathy was not provoked by EAA. 
The most important potential cause of lymph­
adenopathy is tuberculosis, especially since it 
is linked with the epidemiological situation in 
India [10]. One patient had multiple post­tuber­
culosis cavities in his lung. Was enlargement 
of mediastinal lymph nodules observed in this 
patient after antituberculous treatment? Another 
problem is the discrepancy between frequency 
of occurrences of irregular lines in HRCT — in 
Table 2 they were visible in as many as 80% of 
patients and in Table 3 in only 60% [1]. In de­
scribed group of patients it was the most frequent 
finding on computed tomography. However, in 
papers quoted by the authors it was not observed 
[11, 12] or seen only in 29% of patients [7]. The 
authors did not try to explain what might be the 
cause of such a big difference was. It is difficult 
to presume that the patients with EAA in India 
have different radiological abnormalities. More 
probable is a  problem with interpretation of 
computed tomographic findings. Unfortunately, 
neither of the authors of the paper is a radiolo­
gist. It would be useful to ask two independent 
radiologists, with experience in interstitial lung 
diseases, what kind of radiological changes they 
observed. Perhaps these irregular lines were typi­
cal for EAA inter/intra­septal thickening or a kind 
of discrete fibrosis.
Immunological evaluation
Unfortunately, the authors did not evaluate 
the immunological aspects of the disease. Bron­
choalveolar lavage (BAL) could have been carried 
out during bronchofiberoscopy because a percent­
age of lymphocytes in the BAL fluid above 40% is 
one of the major criteria used to diagnose EAA [9]. 
Serological tests were not performed, which in 
spite of good sensitivity were not specific for EAA. 
Morelli et al. [7] discovered precipitins against 
bird antigens in the serum of 92% of patients with 
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EAA but also in 87% of pigeon fanciers without 
the disease. Nevertheless, in the original table of 
diagnostic criteria of EAA by Schuyler & Cormier 
there is mentioned not only evidence of antigen 
exposure, but also specific precipitins in sera or 
BAL fluid [9].
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